RecruitingNot ApplicableNCT05875805

A Telehealth Advance Care Planning Intervention

A Telehealth Advance Care Planning Intervention for Older Patients With Myeloid Malignancies: A Pilot Randomized Controlled Trial

Sponsor

University of Rochester

Enrollment

207 participants

Start Date

May 20, 2024

Study Type

INTERVENTIONAL

Conditions

Acute Myeloid Leukemia Myelodysplastic Syndromes Myelofibrosis Myeloid Malignancy Myelodysplastic/Myeloproliferative Neoplasm

Summary

The objective of this project is to conduct a pilot randomized trial to assess the preliminary efficacy of a telehealth-delivered Serious Illness Care Program on healthcare communication, patient anxiety and distress, as well as completion of advance directives (specifically MOLST and healthcare proxy forms) for older patients with acute myeloid leukemia, myelodysplastic syndrome, and similar myeloid malignancies.

Eligibility

Min Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This study tests whether a telehealth-based program can help patients with certain blood cancers (like AML or MDS) plan ahead for their future medical care. The program uses video visits to guide patients and families through conversations about values, goals, and end-of-life wishes — called advance care planning. **You may be eligible if (as a patient)...** - You are 60 years or older - You have been diagnosed with AML, MDS, myelofibrosis, or a similar blood cancer - You are being treated as an outpatient (not hospitalized) - You speak English **You may be eligible if (as a caregiver)...** - You are 18 or older - You are a family member or close friend chosen by the patient to help with health decisions - You speak English **You may NOT be eligible if...** - You do not meet the above criteria - There are no specific exclusion criteria listed beyond age, diagnosis, and language Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALTelehealth Serious Illness Care Program

The adapted telehealth Serious Illness Care Program is a multilevel intervention engaging the patient, caregiver, clinician, and system. It consists of tools, training, and system change. Tools include: 1) The Serious Illness Conversation Guide for clinicians; and 2) Education materials for patients on the importance of Serious Illness Conversations (Patient Preparation Pamphlet) and of the involvement of caregivers (Family Communication Guide).

OTHEREducation Control

Education materials developed by the NCI on "Communication in Cancer Care (PDQ®) - Patient Version"

Locations(1)

University of Rochester

Rochester, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05875805

Related Trials

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

NCT05564390346 locations

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

NCT05554393177 locations

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

NCT0532019824 locations

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

NCT0417619884 locations

Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

NCT063031931 location